| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |